Nova Leap HealthNVLPF 50 PS Ratio is 0.67 as of Jul. 04, 2026, which is 26% below its 10-year median of 0.90. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.18 (Fairly Valued). The stock has 4 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Nova Leap Health ranks better than 68.59% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Nova Leap Health's share price is $0.24648.
Nova Leap Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.37. Hence, Nova Leap Health's PS Ratio for today is 0.67.
Warning Sign:
Nova Leap Health Corp stock PS Ratio (=0.85) is close to 3-year high of 0.86.
The historical rank and industry rank for Nova Leap Health's PS Ratio or its related term are showing as below:
NVLPF'
s PS Ratio Range Over the Past 10 Years
Min: 0.31 Med: 0.9 Max: 37.5
Current: 0.85
During the past 10 years, Nova Leap Health's highest PS Ratio was 37.50. The lowest was 0.31. And the median was 0.90.
NVLPF's PS Ratio is ranked better than 68.59% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs NVLPF: 0.85
During the past 12 months, the average Revenue per Share Growth Rate of Nova Leap Health was 19.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 1.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.10% per year.
During the past 10 years, Nova Leap Health's highest 3-Year average Revenue per Share Growth Rate was 322.50% per year. The lowest was 1.90% per year. And the median was 6.90% per year.
Back to Basics: PS Ratio
Nova Leap Health (OTCPK:NVLPF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Nova Leap Health PS Ratio Related Terms
Nova Leap Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nova Leap Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Nova Leap Health's Share Price of today is $0.24648. Nova Leap Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.37.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Nova Leap Health (NVLPF) has a PS Ratio of 0.67 as of Jul. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nova Leap Health and its competitors. This is 26% below median its historical median of 0.90. Over the past decade, Nova Leap Health's PS Ratio has ranged from 0.31 to 37.50. According to the industry distribution chart, Nova Leap Health ranks #207 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 31.4%.
Is Nova Leap Health's PS Ratio too high?
Nova Leap Health's current PS Ratio of 0.67 is 26% below median its 10-year median of 0.90. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 37.50. The Healthcare Providers & Services industry median PS Ratio is 1.52. Nova Leap Health's value of 0.67 is 55.9% below this industry median. Based on the distribution chart, Nova Leap Health ranks #207 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #207 out of 659 companies for PS Ratio. This puts Nova Leap Health in the upper half of its industry. The industry median PS Ratio is 1.52. Nova Leap Health's value of 0.67 is 55.9% below this benchmark. Historically, Nova Leap Health's own PS Ratio has ranged from 0.31 to 37.50 over the past decade. While the company's 10-year median is 0.90 vs. the industry median of 1.52, Nova Leap Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current PS Ratio of 0.67 is 55.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current PS Ratio is 0.67, which is 26% below median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.18, compared to a current price of $0.25 — trading 36.9% above its estimated fair value. The current PS Ratio is 0.67, which is 26% below median its 10-year median of 0.90 and 55.9% below the Healthcare Providers & Services industry median of 1.52. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current PS Ratio is 0.67 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.25 is trading 36.9% above its estimated GF Value™ of $0.18.
GuruFocus considers Nova Leap Health to be Fairly Valued.
Key valuation signals for NVLPF:
PS Ratio: 0.67 (26% below median its 10-year median of 0.90)
GF Value™: $0.18 vs. price of $0.25 (36.9% above fair value)
Industry Position: 55.9% below the Healthcare Providers & Services median (#207 of 659)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score
Get the complete analysis for NVLPF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 
